Ahammune Biosciences raises $5 million to fund novel vitiligo therapy
Pune-based Ahammune Biosciences, a clinical stage therapeutics company working towards creating new ways to treat and cure skin diseases, has raised a Series A funding round of $5 million led by pi Ventures.
More in IT
